Oral tapentadol for cancer pain

BACKGROUND: A large proportion of people with advanced cancer will experience moderate to severe pain. Tapentadol is a novel, centrally acting analgesic medicine acting at the μ‐opioid receptor and inhibiting noradrenaline reuptake. The efficacy of tapentadol is stated to be comparable to morphine a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Wiffen, Philip J, Derry, Sheena, Naessens, Katrien, Bell, Rae Frances
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2015
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483480/
https://ncbi.nlm.nih.gov/pubmed/26403220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011460.pub2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker